Life Science Investment Opportunity in
Israel
Dalia Megiddo, MD, MBA
Managing Partner, InnoMed
April 2005
2003-2005 -$2B exits
from life science co’s
Guidant- X tech 200M
Kodak – Algotec 50M
Edwards – PVT
130M
Kodak-Orex 50M
Siemens- Cadvision ND
Syneron – IPO+follow on
740M
Shamir - IPO
250M
Israeli team wins the Nobel Prize
( Ubiquitin)
• Investment in
Education
• Multiple research
institutes
• Educated
workforce
• Financial
incentives:
Tax exemptions
Incubators
Incentives for
foreign investors
RD focus
Civilian RD
Defense RD
Collaboration
programs
National incentive system
Highest investment in education as %
of GDP
Multitude of research and
higher education opportunities
7 major
universities and
research institutes
Multitude of
colleges and
higher education
institutes
Highly educated workforce
Highest RD focus
Generous incentives
High patent per capita ratio
Areas of excellence
Israel is ranked world’s 2nd source
for medical technology
Technology Sources :
Defense technologies
Russian immigration
Local talent
People :
Innovative, entrepreneurial
Interdisciplinary development culture
Highest R&D yield per investment
Israeli medical blockbusters
MX-8000 CT scanner –
Elscint / Philips
Hawkeye SPECT scanner –
Elscint / GE
Nir stent – Medinol
Rebif Multiple Sclerosis therapy – Serono
Copaxone Multiple Sclerosis therapy – Teva
M2A GI video capsule – Given Imaging
Israel - a “fertile ground” for
international corporations
Equity position in companies:
Boston Scientific - Medinol,Sightline
Medtronic - Itamar,Odin
J&J - Ness , Topspin, Medgenics
Guidant - Remon
AGFA - MediVision
Suzuken Co. Ltd – Glucon, Given
Fujisawa Pharmaceutical - QBI
Equity position in funds:
Boston Scientific, J&J, Tyco, B&L
M&A’s :
GE - Elscint, Diasonics; Philips – Elscint; J&J - Biosense ; Medtronic - Instent ;Guidant
- X Tech;
Kodak - Algotec ;Edward Li